Follow up study of Phase II clinical trial of OCV-501
Not Applicable
- Conditions
- acute myeloid leukemia
- Registration Number
- JPRN-UMIN000045499
- Lead Sponsor
- ational Hospital Organization Nagoya Medical Center IRB
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 133
Inclusion Criteria
Not provided
Exclusion Criteria
1) Cases showing a manifestation of non-participation in this study 2) Cases who the principal investigator deems inappropriate as a research subject
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 5-year disease free survival; OCV-501 group vs. placebo group
- Secondary Outcome Measures
Name Time Method 5-year overall survival; OCV-501 group vs. placebo group Specific immunological responses to WT-1 and prognosis Level of WT1 mRNA and prognosis